Atlas Trials

A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia

Clinical trial NCT05219721 · RECRUITING

Trial details

NCT number
NCT05219721
Sponsor
Chunrui Li
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Relapsed/Refractory Multiple MyelomaPlasma Cell Leukemia
Start date
2022-03-17
Primary completion
2025-09-01
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.